Why R&D innovation holds the key to greater patient impact
European Pharmaceutical Review
MAY 2, 2023
billion in 2022, the average projected return on investment (ROI) in R&D was just 1.2 By collaborating with several stakeholders and authorities, multiple stages of development can take place concurrently to speed up R&D without compromising safety protocols. The COVID-19 blueprint has shown a way forward. Cancer Research UK.
101 
Let's personalize your content